Cortical spreading depression: Its role in migraine pathogenesis and possible therapeutic intervention strategies

Current Pain and Headache Reports

Volumn 8, Issue 5, 2004, Pages 410-416

  Parsons, Andrew A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; ANTIMIGRAINE AGENT; BTS 72664; DIZOCILPINE; ERGOTAMINE; FUROSEMIDE; HALOTHANE; KETAMINE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; PROPRANOLOL; SILDENAFIL; SUMATRIPTAN; TONABERSAT; UNCLASSIFIED DRUG; VALPROIC ACID; XENON; ZAPRINAST;

BLOOD OXYGENATION; BRAIN FUNCTION; BRAIN INJURY; CELL ACTIVATION; CLINICAL STUDY; DATA ANALYSIS; DIFFUSION WEIGHTED IMAGING; DRUG MECHANISM; ELECTROCORTICOGRAPHY; EXPERIMENTAL ANIMAL; HUMAN; MEDICAL DECISION MAKING; MIGRAINE; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOMENOLOGY; POSITRON EMISSION TOMOGRAPHY; REPOLARIZATION; REVIEW; SENSITIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPREADING CORTICAL DEPRESSION; TREATMENT PLANNING;

EID: 5144226204     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-996-0016-0     Document Type: Review

References (58)

1. Leao AA: Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944a, 7:359-390.
2. Leao AA: Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 1944b, 7:391-396.
3. Marshall WH: Spreading cortical depression of Leao. Phys Rev 1957, 39:239-279.
4. Lauritzen M: Pathophysiology of migraine aura: the spreading depression theory. Brain 1994, 117:199-210.
5. Reid KH, Marrannes R, Wauquier A: Spreading depression and central nervous system pharmacology. J Pharmacol Methods 1988, 19:1-21.
6. Laurotzen M: Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2 response. J Cereb Blood Flow Metab 1984, 4:546-554.
7. Richter F, Lehmenkeuhler A: Spreading depression can be restricted to distinct depths of the rat cerebral cortex. Neurosci Lett 1993, 152:65-68
8. McLachlan RS, Girvin JP: Spreading depression of Leao in rodent and human cortex. Brain Res 1994, 666:133-136.
9. Mayevsky A, Doron A, Manor T, et al.: Cortical spreading depression recorded from human brain using a multiparametric monitoring system. Brain Res 1996, 740:268-274.
10. Strong AJ, Smith SE, Whittington DJ, et al.: Factors influencing the frequency of fluorescence transients as markers of periinfarct depolarizations in focal cerebral ischemia. Stroke 2000, 31:214-222.
11. Gorji A, Scheller D, Straub H, et al.: Spreading depression in human neocortical slices. Brain Res 2001, 906:74-83.
12. Guedes RC, Cavalthreiro EA: Blockade of spreading depression in chronic epileptic rats. Epilepsy Res 1997, 27:133-136.
13. Strong AJ, Fabricus M, Boutelle MG, et al.: Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 2002, 33:2738-2743.
14. James ME, Smith MI, Bockhorst KH, et al.: Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol 1999, 519:415-425.
15. Gardner-Medwin AR, van Bruggen N, Williams SR, Ahier RG: Magnetic resonance imaging of propagating waves of spreading depression in the anesthetized rat. J Cereb Blood Flow Metab 1994, 14:7-11.
16. Woods RP, Iacobini M, Mazziotta JC: Bilateral spreading cerebral hypoperfusion during spontaneous migraine. N Engl J Med 1994, 331:1689-1692.
17. Russell MB, Olesen J: A nosographic analysis of the migraine aura in a general population. Brain 1996, 119:355-361.
18. Lashley KS: Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry Chicago 1941, 46:331-339.
19. Milner PM: Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. Electroencephalogr Clin Neurophysiol Suppl 1958, 10:705.
20. Barkley GL, Tepley N, Simkins R, et al.: Neuromagnetic fields in migraine: preliminary findings. Cephalalgia 1990, 10:171-176.
21. Hadjikhani N, Sanchez del Rio M, Wu O, et al.: Mechanisms of migraine aura revealed by fMRI in human visual cortex. Proc Natl Acad Sci U S A 2001, 98:4687-4692.
22. Lauritzen M, Olesen J: Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain 1984, 107:447-461.
23. Olesen J, Lauritzen M, Tflet-Hansen P, et al.: Spreading cerebral oligemia in classical and normal cerebral blood flow in common migraine. Headache 1982, 22:242-248.
24. Andersson JL, Muhr C, Lilja A, et al.: Regional cerebral blood flow and oxygen metabolism with and without aura. Cephalalgia 1997, 17:570-579.
25. Cao Y, Welch KM, Aurora S, Vikingstad E: Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999, 56:548-554.
26. Cutrer FM, Sorensen AG, Weisskoff RM, et al.: Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998, 43:25-31.
27. Sanchez del Rio M, Bakker D, Wu O, et al.: Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999, 19:1-7
28. Colonna DM, Meng W, Deal DD, Busija DW: Calcitonin gene-related peptide promotes cerebrovascular dilatation during cortical spreading depression in rabbits. Am J Physiol 1994, 266:H1095-H1102.
29. Wahl M, Schilling L, Parsons AA, Kaumann AJ: Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 1994, 637:204-210.
30. Reuter U, Weber JR, Gold L, et al.: Perivascular nerves contribute to cortical spreading depression-associated hyperemia in rat. Am J Physiol 1998, 274:H1979-H1987.
31. McCulloch J, Uddman R, Kingman TA, Edvinsson L: Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986, 83:5731-5735.
32. Moskowitz MA, Nozaki K, Kraig RP: Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within the trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993, 13:1167-1177.
33. Ingvardsen BK, Laursen H, Olsen UB, Hansen AJ: Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression. Pain 1998, 76:265-267.
34. Lambert GA, Michalicek J, Storer RJ, Zagami AS: Effect of cortical spreading depression on activity of trigeminovascular sensory neurons. Cephalalgia 1999, 19:631-638.
35. Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
36. Strassman AM, Raymond SA, Burstein R: Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384:560-564.
37. Burstein R, Yamamura H, Mlick A, Strassman AM: Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998, 79:964-982.
38. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614-624.
39. Burstein R, Cutter FM, Yarnitsky D: The development of cutaneous allodynia during migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurones in migraine. Brain 2000, 123:1703-1709.
40. Burstein R, Collins B, Jakubowski M: Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004, 55:19-26.
41. Jander S, Schroeter M, Peteres O, et al.: Cortical spreading depression induces proinflammatory gene expression in the rat brain. J Cerebral Blood Flow Metab 2001, 21:218-215.
42. Caggiano AO, Breder CD, Kraig RP: Long-term elevation of cyclooxygenase-2, but not lipoxygenase, in regions synaptically distant from spreading depression. J Comp Neurol 1996, 376: 447-462.
43. Shen PJ, Gundlach AL: Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD- and NO-mediated neuroprotection. Exp Neurol 1999, 160:317-312.
44. Read SJ, Hirst WD, Upton N, Parsons AA: Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 2001, 891:69-77.
45. Arakawa S, Nakamura S, Kawashima N, et al.: Antidromic burst activity of locus coeruleus neurons during cortical spreading depression. Neuroscience 1997, 78:1147-1158.
46. Contreras D, Destexhe A, Steriade M: Spindle oscillations during cortical spreading depression in naturally sleeping cats. Neuroscience 1997, 77:933-936.
47. Obrenovitch TP, Zilkha E: Inhibition of spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor. Br J Pharmacol 1996, 117:931-937.
48. Kaube H, Herzog J, Kaufer T, et al.: Aura in some patients with familial hemiplegic migraine can be stopped with ketamine. Neurology 2000, 55:139-141.
49. Piper RD, Lambert GA: Inhalational anesthetics inhibit spreading depression: relevance to migraine. Cephalalgia 1996, 16:87-92.
50. Kaube H, Goadsby PJ: Antimigraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol 1994, 34:30-35.
51. Smith SL, Thompson KS, Sargent BJ, Heal DJ: BTS-72664: a novel CNS drug with potential anticonvulsant, neuroprotective, and antimigraine properties. CNS Drug Rev 2001, 7:146-171.
52. Read SJ, Smith MI, Benham CD, et al.: Furosemide inhibits regenerative spreading depression in anesthetized cats. Cephalalgia 1997, 17:826-832.
53. Chan WN, Evans JM, Hadley MS, et al.: (-)-cis-6-acetyl-4S-(3-chloro-4-fluro-benzoylamino)-3,4-dihydro-2, 2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorg Med Chem Lett 1999, 8:2903-2906.
54. Bradley DP, Smith MI, Netsiri C, et al.: Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Exp Neurol 2001, 172:342-353.
55. Marrannes R, Wauquier A, Reid K, De Prine E: Effects of drugs on cortical spreading depression. In Prelude to the Migraine Attack. Edited by Amery WK, Wauquier A. London: Bailliere Tindell; 1986:158-173.
56. Van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al.: A CACNALA knocking migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004, 41:701-710.
57. Obrenovitch TP, Urenjak J, Wang M: Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab 2002, 22:680-688.
58. Wang M, Urenjak J, Fedele E, Obrenovitch TP: Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP. Biochem Pharmacol 2004, 67:1619-1627.